期刊文献+

单纯细支气管肺泡癌42例生存率及预后因素探讨

Studies on factors affecting the prognosis of 42 patients with pure bronchioloalveolar carcinoma
原文传递
导出
摘要 目的探讨影响单纯型细支气管肺泡癌(BAC)患者的预后因素。方法根据2004年BAC最新定义,在156例BAC中选取符合标准的单纯型BAC42例进行回顾性分析,按首次就诊时有无临床症状、TNM分期、影像学分型以及细胞生物学指标Ki67、p53进行分组配对,先用χ2检验最后用Cox模型分析处理各组数据。结果42例患者中位生存时间50个月,其1、2、3、5年总生存率分别为100%、95%、84%、62%;按TNM分期,Ⅰ+Ⅱ期和Ⅲ+Ⅳ期患者的1、2、3、5年生存率分别为100%、95%、92%、86%和100%、90%、74%、53%(P<0.05)。首诊时患者有无症状、影像学分型以及细胞p53表达也与生存预后相关。Cox多因素分析提示首诊时有无症状和TNM分期是独立的预后影响因子。结论影响单纯BAC5年生存率的主要因素有患者首诊时有无临床症状及TNM分期,总体生存率较高。 Objective To explore the factors that affecting the prognosis of early stage pure bronchioloalveolar carcinoma(BAC).Methods Reference to the latest identification of BAC in 2004,42 patients with pure BAC from 156 BAC patients were studied retrospectively.According to the symptoms appeared or not,TNM staging,imaging typing and the expressions of cell p53,Ki67,the patients were divided into groups and the 1-year,2-year,3-year,and 5-year survive rate of them were obtained respectively.The χ2 test and Cox modal analysis were used to compare the difference of survivals between/among the groups.Results The overall 1-year,2-year,3-year,and 5-year survival rate was 100%,95%,84% and 62%,with median survival time(MST)fifty months.The rates were 100%,95%,92%,86% and 100%,90%,74%,53% in the groups of TNM stage Ⅰ+Ⅱ and Ⅲ+Ⅳ,respectively(P〈0.05).There were lower survivals in the symptomatic group,the pneumonia typing group and high cell express p53 group.Cox regression analysis suggests that symptoms and TNM stage are independent factors affecting progresis.Conclusions The factors affecting the survival rate of pure BAC patients are the clinical manifestations of the patients,TNM stage.Overall survival rate was superior to other NSCLC.
出处 《中华临床医师杂志(电子版)》 CAS 2009年第8期27-31,共5页 Chinese Journal of Clinicians(Electronic Edition)
关键词 腺癌 细支气管肺泡 存活率 预后 Adenocarcinoma,bronchiolo-alveolar Survival rate Prognosis
  • 相关文献

参考文献1

二级参考文献10

  • 1[2]Goodwin LO,Mason JM,Hajdu SI.Gene expression patterns of paired bronchioloalveolar carcinoma and benign lung tissue.Ann Clin Lab Sci,2001,31(4):369
  • 2[4]Furak J,Trojan I,Szoke T,et al.Bronchioloalveolar lung cancer:Occurrence,surgical treatment and survival.Eur Cardiothorac Surg,2003,23:818
  • 3[5]Volpino P,D Andrea N,Cangemi R,et al.Bronchioloalveolar carcinoma:Clinical,radiographic,and pathological findings.Surgical results.J Cardiovasc Surg (Torino),2001,42(2):261
  • 4[6]Roberts PF,Straznicka M,Lara PN.et al.Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved.J Thorac Cardiovasc Surg,2003,126:1597
  • 5[7]West HL,Crowley JJ,Vance RB,et al.Advanced bronchioloalveolar carcinoma:A phase Ⅱ trial of paclitaxel by 96-hour infusion (SWOG 9714).Ann Oncol:(In press).
  • 6[8]West H,Franklin WA,McCoy J,et al.Gefitinib therapy in advanced bronchioloalveolar carcinoma:Southwest Oncology Group Stady S0126.J Clin Oncol,2006,24 (12):1807
  • 7[9]Kris MG,Sandler A,Miller V,et al.Cignrrette smoking history predicts sensitivity to erlotinib:Results of a phase Ⅱ trial in patients with bronchioloalveolar carcinoma (BAC).Proc Am Soc Clin Oncol,2004,23:631S
  • 8[10]Ebright MI,Zakowski MF,Martin J,et al.Clinical pattern and patho2-logic stage but not histologic features predict outcome for bronchi-oloalveolar carcinoma.Ann Thorac Surg,2002,74(5):1640 discussion 1646
  • 9贾心善,何安光,张道荣,王恩华,宋继谒.沈阳地区1224例肺癌20世纪80年代与90年代临床病理比较[J].中华病理学杂志,2001,30(5):332-335. 被引量:19
  • 10赵兰,褚海青,李惠萍,何国钧.吉西他滨、顺铂联合治疗晚期细支气管肺泡癌[J].中国肺癌杂志,2002,5(6):467-468. 被引量:8

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部